Excess mortality related to cefepime.
Leibovici
Leonard
L
Yahav
Dafna
D
Paul
Mical
M
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000401:mortality*; D000077723:Cefepime; D002511:Cephalosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009026:Mortality; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000077723:Cefepime